Waisman Center
Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.

Sphingolipid Profiling: A Promising Tool for Stratifying the Metabolic Syndrome-Associated Risk

Coe, PhD, C. L. Sphingolipid Profiling: A Promising Tool for Stratifying the Metabolic Syndrome-Associated Risk.
Berkowitz, L., Cabrera-Reyes, F., Salazar, C., Ryff, C. D., Coe, C., & Rigotti, A. (2022). Sphingolipid Profiling: A Promising Tool for Stratifying the Metabolic Syndrome-Associated Risk. Frontiers in cardiovascular medicine, 8, 785124. https://doi.org/10.3389/fcvm.2021.785124